TRPM4 expression is regulated by the tumor suppressor protein p53, and the loss of p53 function in advanced CRC increases TRPM4 expression, which may explain its differing effects in early and late-stage CRC patients [89]. This evidence concerns the gene TP53 and colorectal carcinoma.